Page last updated: 2024-08-23

brimonidine tartrate and Erythema

brimonidine tartrate has been researched along with Erythema in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	32 (72.73)	24.3611
2020's	12 (27.27)	2.80

Authors

Authors	Studies
Agamia, N; El-Ariny, A; El-Nagdy, S	1
Dadkhahfar, S; Etesami, I; Kalantari, Y	1
Coto-Segura, P; García García, B; Mir-Bonafé, M; Pérez González, LA	1
Chen, DW; Chen, QQ; Fu, J; Li, J; Li, X; Ni, RR; Song, GJ; Song, ZQ; Tang, JY; Wan, M; Zhang, MW	1
Bernhard, D; Clanner-Engelshofen, BM; Dargatz, S; Flaig, MJ; Gieler, U; Kinberger, M; Klövekorn, W; Kuna, AC; Läuchli, S; Lehmann, P; Nast, A; Pleyer, U; Reinholz, M; Schaller, M; Schöfer, H; Schwennesen, T; Steinhoff, M; Werner, RN; Zierhut, M	1
Kim, CY; Lee, JS	1
Ahramiyanpour, N; Amani, M; Hosseini, SA; Nezhad, NZ; Saki, N; Shafiei, M; Shahpar, A	1
Abdelhameed, SS; El-Domyati, M; Medhat, W; Nasif, G; Rezk, AF	1
Gold, MH; Ivanic, MG; Javadi, SS; Norden, A; Oulee, A; Wu, JJ	1
Dahlin, J; Sukakul, T; Svedman, C	1
Rusina, T; Snarskaya, E	1
Kim, JM; Kwon, HJ; Lee, SJ; Park, KY	1
Bhatt, K; Dall'Oglio, F; Lacarrubba, F; Luppino, I; Micali, G; Verzì, AE	1
Kim, H; Kim, HS; Lee, SJ	1
Cline, A; Feldman, SR; McGregor, SP	1
Gil, D; Hsia, E; Tian, M	1
Bonamonte, D; Filoni, A; Giudice, G; Vestita, M	1
Dierickx, C; Haedersdal, M; Karmisholt, KE; Vissing, AE	1
Ahn, GR; Kim, BJ; Lee, SJ; Nam Kim, M; Park, KY; Seo, SB	1
Johansen, UB; Wiegell, SR; Wulf, HC	1
Bertino, B; Blanchet-Réthoré, S; Bogouch, A; Bourdès, V; Dugaret, AS; Gamboa, B; Méhul, B; Nonne, C; Petit, L; Piwnica, D; Reynier, P; Roquet, M; Thibaut de Ménonville, S; Vial, E; Voegel, JJ; Zugaj, D	1
Cline, A; Feldman, SR; Okwundu, N	1
Del Rosso, JQ	1
Kempers, S; Leoni, M; Liu, H; Moore, A; Murakawa, G; Swinyer, L; Tauscher, A; Weiss, J	1
Levitt, JO; Routt, ET	1
Berson, D; Del Rosso, JQ; Eichenfield, LF; Gallo, R; Stein-Gold, L; Tanghetti, E; Thiboutot, D; Webster, G; Zaenglein, A	1
Ilkovitch, D; Pomerantz, RG	1
Fowler, J; Jackson, JM; Jarratt, M; Jones, T; Leoni, M; Meadows, K; Moore, A; Rudisill, D; Steinhoff, M	1
Fowler, J; Jackson, JM; Jarratt, M; Jones, T; Leoni, M; Meadows, K; Tan, J	1
Moore, AY; Tong, LX	1
Hougeir, FG	1
Collgros, H; Lamas-Doménech, N	1
Kobayashi, TT; Werner, K	1
Aires, D; Fischer, R; Gillihan, R; Nguyen, T; Rajpara, A	1
Rajagopalan, A; Rajagopalan, B	1
Leoni, M; Tan, J	1
Bewley, AP; Hofmann, MA; Homey, B; Kerrouche, N; Layton, AM; Lehmann, P; Ma, YM; Nohlgård, C; Sarwer, DB; Schaller, M	1
Schauber, J; Schmelz, M; Steinhoff, M	1
Gerber, PA	1
Del Barrio-Díaz, P; Moll-Manzur, C; Vera-Kellet, C	1
Lim, S; Lowe, E	1
Artzi, O; Braun, SA; Gerber, PA	1
Fowler, J; Jarratt, M; Leoni, M; Liu, Y; Meadows, K; Moore, A; Pollack, A; Steinhoff, M	1

Reviews

10 review(s) available for brimonidine tartrate and Erythema

Article	Year
Post-acne erythema treatment: A systematic review of the literature. Journal of cosmetic dermatology, 2022, Volume: 21, Issue:4 Topics: Acne Vulgaris; Brimonidine Tartrate; Erythema; Humans; Lasers, Dye; Lasers, Solid-State; Treatment Outcome	2022
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy. Expert review of clinical pharmacology, 2022, Volume: 15, Issue:8 Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Erythema; Humans; Hyperemia; Nasal Decongestants; Ophthalmic Solutions; Quality of Life; Quinoxalines; Receptors, Adrenergic	2022
Efficacy and safety of topical brimonidine in dermatology: A review article. Dermatologic therapy, 2022, Volume: 35, Issue:11 Topics: Brimonidine Tartrate; Dermatology; Erythema; Humans; Rosacea; Treatment Outcome	2022
Neurogenic Rosacea Treatment: A Literature Review. Journal of drugs in dermatology : JDD, 2023, Jun-01, Volume: 22, Issue:6 Topics: Anti-Bacterial Agents; Brimonidine Tartrate; Erythema; Humans; Metronidazole; Rosacea	2023
Topical Brimonidine Tartrate 0.33% Gel on Postlaser Erythema: Our Experience and Review of the Literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:1 Topics: Brimonidine Tartrate; Erythema; Facial Dermatoses; Female; Gels; Humans; Laser Therapy; Male; Middle Aged; Vasoconstrictor Agents; Young Adult	2018
Medical Management of Facial Redness in Rosacea. Dermatologic clinics, 2018, Volume: 36, Issue:2 Topics: Administration, Cutaneous; Adrenergic alpha-Agonists; Antihypertensive Agents; Brimonidine Tartrate; Calcineurin Inhibitors; Erythema; Face; Humans; Off-Label Use; Oxymetazoline; Retinoids; Rosacea; Tetracyclines	2018
Difference in vasoconstrictors: oxymetazoline vs. brimonidine. The Journal of dermatological treatment, 2021, Volume: 32, Issue:2 Topics: Administration, Topical; Brimonidine Tartrate; Clinical Trials as Topic; Dermatitis; Erythema; Humans; Oxymetazoline; Rosacea; Treatment Outcome; Vasoconstrictor Agents	2021
Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea. Expert review of clinical pharmacology, 2014, Volume: 7, Issue:5 Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Erythema; Humans; Quality of Life; Quinoxalines; Rosacea; Treatment Outcome	2014
Brimonidine for erythema caused by rosacea. Drug and therapeutics bulletin, 2014, Volume: 52, Issue:12 Topics: Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Contraindications; Drug Costs; Drug Interactions; Erythema; Humans; Quinoxalines; Rosacea	2014
Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options. Acta dermato-venereologica, 2016, Jun-15, Volume: 96, Issue:5 Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Antihypertensive Agents; Brimonidine Tartrate; Erythema; Humans; Rosacea	2016

Trials

11 trial(s) available for brimonidine tartrate and Erythema

Article	Year
Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety/depression. The Journal of dermatology, 2022, Volume: 49, Issue:11 Topics: Adult; Anxiety; Brimonidine Tartrate; Carvedilol; Depression; Erythema; Humans; Rosacea	2022
Treatment of erythemato-telangiectatic rosacea with brimonidine alone or combined with vascular laser based on preliminary instrumental evaluation of the vascular component. Lasers in medical science, 2018, Volume: 33, Issue:6 Topics: Administration, Cutaneous; Adult; Brimonidine Tartrate; Combined Modality Therapy; Dermoscopy; Erythema; Female; Gels; Humans; Lasers, Solid-State; Male; Middle Aged; Photography; Rosacea; Telangiectasis; Treatment Outcome; Young Adult	2018
Topical brimonidine reduces IPL-induced erythema without affecting efficacy: A randomized controlled trial in patients with facial telangiectasias. Lasers in surgery and medicine, 2018, Volume: 50, Issue:10 Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Edema; Erythema; Face; Female; Humans; Laser Therapy; Male; Middle Aged; Postoperative Complications; Single-Blind Method; Telangiectasis; Treatment Outcome	2018
Pulse-Daylight-Photodynamic Therapy in Combination with Corticosteroid and Brimonidine Tartrate for Multiple Actinic Keratoses: A Randomized Clinical Trial. Acta dermato-venereologica, 2019, Feb-01, Volume: 99, Issue:2 Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adrenergic alpha-2 Receptor Agonists; Aminolevulinic Acid; Brimonidine Tartrate; Clobetasol; Denmark; Erythema; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Time Factors; Treatment Outcome	2019
Brimonidine displays anti-inflammatory properties in the skin through the modulation of the vascular barrier function. Experimental dermatology, 2018, Volume: 27, Issue:12 Topics: Administration, Cutaneous; Adolescent; Adult; Animals; Anti-Inflammatory Agents; Brimonidine Tartrate; Cell Movement; Dermatitis; Endothelial Cells; Erythema; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Middle Aged; Neutrophils; Proteome; Rosacea; Skin; Ultraviolet Rays; Vasodilation; Young Adult	2018
Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study. Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:1 Topics: Administration, Cutaneous; Administration, Topical; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Erythema; Face; Female; Humans; Male; Middle Aged; Quinoxalines; Rosacea; Social Behavior; Treatment Outcome; Young Adult	2014
Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea. Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:6 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Dermatologic Agents; Double-Blind Method; Erythema; Female; Gels; Humans; Male; Middle Aged; Quinoxalines; Rosacea; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult	2014
Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:3 Topics: Adult; Brimonidine Tartrate; Double-Blind Method; Erythema; Face; Female; Humans; Male; Middle Aged; Patient Satisfaction; Rosacea	2015
Erythema of Rosacea: Validation of Patient's Self-Assessment Grading Scale. Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:8 Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Brimonidine Tartrate; Diagnostic Self Evaluation; Double-Blind Method; Erythema; Facial Dermatoses; Female; Gels; Humans; Male; Reproducibility of Results; Rosacea; Severity of Illness Index; Young Adult	2015
Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:12 Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Brimonidine Tartrate; Erythema; Facial Dermatoses; Female; Gels; Humans; Male; Middle Aged; Patient Satisfaction; Rosacea; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult	2015
Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. The British journal of dermatology, 2012, Volume: 166, Issue:3 Topics: Administration, Cutaneous; Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Brimonidine Tartrate; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Facial Dermatoses; Female; Gels; Humans; Male; Middle Aged; Quinoxalines; Rosacea; Treatment Outcome; Young Adult	2012

Other Studies

23 other study(ies) available for brimonidine tartrate and Erythema

Article	Year
A split face comparative study using a novel triple combination therapy for the treatment of persistent post acne erythema. Dermatologic therapy, 2022, Volume: 35, Issue:4 Topics: Acne Vulgaris; Administration, Topical; Brimonidine Tartrate; Drug Therapy, Combination; Erythema; Humans; Oxymetazoline; Rosacea; Treatment Outcome	2022
Rapid and sustained improvement of dupilumab-associated head and neck erythema with topical brimonidine. Dermatologic therapy, 2022, Volume: 35, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Brimonidine Tartrate; Erythema; Humans; Rosacea	2022
S2k guideline: Rosacea. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2022, Volume: 20, Issue:8 Topics: Brimonidine Tartrate; Dermatologic Agents; Erythema; Humans; Ivermectin; Metronidazole; Rosacea	2022
Topical brimonidine for the management of facial erythema in rosacea: a histological, histometric, and immunohistochemical study. International journal of dermatology, 2023, Volume: 62, Issue:7 Topics: Administration, Cutaneous; Brimonidine Tartrate; Erythema; Humans; Ophthalmic Solutions; Rosacea; Treatment Outcome	2023
Primum non nocere; the importance of evaluating the effect of treatment and considering side effects. Contact dermatitis, 2021, Volume: 84, Issue:2 Topics: Anti-Inflammatory Agents; Brimonidine Tartrate; Budesonide; Dermatologic Agents; Diagnosis, Differential; Erythema; Facial Dermatoses; Humans; Hydrocortisone; Male; Middle Aged; Patch Tests; Rosacea	2021
Erythematotelangiectatic rosacea: The combination of 0.5% brimonidine tartrate gel and broadband pulse light therapy to reverse its effects. Journal of cosmetic dermatology, 2021, Volume: 20, Issue:7 Topics: Brimonidine Tartrate; Dermatologic Agents; Erythema; Humans; Phototherapy; Rosacea	2021
Topical brimonidine gel for extended-duration local anaesthesia. Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:1 Topics: Adrenergic alpha-2 Receptor Agonists; Anesthesia, Local; Anesthetics, Local; Brimonidine Tartrate; Erythema; Facial Dermatoses; Gels; Humans; Intense Pulsed Light Therapy; Lentigo; Lidocaine; Male; Middle Aged; Pain, Procedural; Time Factors	2018
Reduction in ultraviolet B light-induced erythema by oxymetazoline and brimonidine is mediated by different α-adrenoceptors. Experimental dermatology, 2018, Volume: 27, Issue:7 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Calcium; Disease Models, Animal; Erythema; HEK293 Cells; Humans; Male; Mice; Mice, Hairless; Oxymetazoline; Prazosin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Rosacea; Ultraviolet Rays; Vasoconstriction; Yohimbine	2018
Image Gallery: Brimonidine gel for facial erythema in Netherton syndrome. The British journal of dermatology, 2018, Volume: 178, Issue:4 Topics: Administration, Cutaneous; Adult; Brimonidine Tartrate; Dermatologic Agents; Erythema; Facial Dermatoses; Female; Gels; Humans; Netherton Syndrome; Off-Label Use	2018
Topical brimonidine-assisted laser treatment for the prevention of therapy-related erythema and hyperpigmentation. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2019, Volume: 21, Issue:4 Topics: Administration, Topical; Adolescent; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Erythema; Humans; Hyperpigmentation; Low-Level Light Therapy; Male; Middle Aged; Tattooing	2019
Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy? Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:6 Suppl 1 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Brimonidine Tartrate; Erythema; Humans; Oxymetazoline; Quinoxalines; Rosacea; Sympathetic Nervous System; Vasodilation	2013
Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33%. Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:2 Topics: Administration, Cutaneous; Adult; Brimonidine Tartrate; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Gels; Humans; Pain; Quinoxalines; Recurrence; Risk Assessment; Rosacea; Sampling Studies; Severity of Illness Index	2014
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. Cutis, 2014, Volume: 93, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Adrenergic alpha-2 Receptor Agonists; Anti-Infective Agents; Brimonidine Tartrate; Consensus; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Erythema; Humans; Metronidazole; Quinoxalines; Rosacea; Severity of Illness Index; Societies, Medical	2014
Brimonidine effective but may lead to significant rebound erythema. Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:5 Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Brimonidine Tartrate; Erythema; Female; Humans; Quinoxalines; Rosacea; Vasoconstriction	2014
[Erythema of rosacea: a new and effective treatment]. Annales de dermatologie et de venereologie, 2014, Volume: 141 Suppl 2 Topics: Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Erythema; Female; Humans; Male; Middle Aged; Quinoxalines; Rosacea; Treatment Outcome	2014
Facial erythema: keys to the differential diagnosis. Actas dermo-sifiliograficas, 2015, Volume: 106, Issue:5 Topics: Alcohol Drinking; Biomarkers; Brimonidine Tartrate; Diagnosis, Differential; Emotions; Endocrine System Diseases; Erythema; Facial Dermatoses; Flushing; Humans; Neoplasms; Symptom Assessment	2015
Dermatitis medicamentosa: severe rebound erythema secondary to topical brimonidine in rosacea. Dermatology online journal, 2015, Jan-01, Volume: 21, Issue:3 Topics: Adult; Brimonidine Tartrate; Dermatologic Agents; Drug Eruptions; Erythema; Female; Humans; Rosacea	2015
Erythema in Skin Adjacent to Area of Long-term Brimonidine Treatment for Rosacea: A Novel Adverse Reaction. JAMA dermatology, 2015, Volume: 151, Issue:10 Topics: Brimonidine Tartrate; Dermatologic Agents; Drug Eruptions; Erythema; Female; Humans; Middle Aged; Rosacea; Time Factors	2015
Allergic contact dermatitis to topical brimonidine. The Australasian journal of dermatology, 2015, Volume: 56, Issue:3 Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Drug Eruptions; Erythema; Facial Dermatoses; Humans; Male; Middle Aged	2015
Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy. The British journal of dermatology, 2016, Volume: 174, Issue:6 Topics: Administration, Cutaneous; Adrenergic alpha-2 Receptor Agonists; Adult; Brimonidine Tartrate; Drug Eruptions; Erythema; Facial Dermatoses; Gels; Humans; Male; Photochemotherapy; Rosacea; Sunlight	2016
Brimonidine gel for the treatment of recalcitrant facial erythema in diseases other than rosacea: a novel tool for clinicians. Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:1 Topics: Adult; Brimonidine Tartrate; Erythema; Face; Female; Gels; Humans	2017
Paradoxical Erythema Reaction of Long-term Topical Brimonidine Gel for the Treatment of Facial Erythema of Rosacea. Journal of drugs in dermatology : JDD, 2016, Jun-01, Volume: 15, Issue:6 Topics: Administration, Cutaneous; Adult; Brimonidine Tartrate; Drug Administration Schedule; Erythema; Female; Gels; Humans; Rosacea; Treatment Outcome	2016
Brimonidine tartrate 0.33% gel for the management of posttreatment erythema induced by laser skin resurfacing. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:2 Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Brimonidine Tartrate; Cosmetic Techniques; Erythema; Female; Gels; Humans; Laser Therapy	2017